News & Events - News Releases

Keyword Search
 
2006
DateTitle 
10/29/14Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2015 On November 4, 2014Printer Friendly Version
09/29/14Phase 2 Trial Of Binimetinib In NRAS Melanoma Shows Promising Clinical ActivityPrinter Friendly Version
09/11/14Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical OfficerPrinter Friendly Version
09/03/14Array BioPharma To Present At The Morgan Stanley 2014 Global Healthcare ConferencePrinter Friendly Version
08/12/14Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014Printer Friendly Version
07/28/14Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 On August 12, 2014Printer Friendly Version
06/11/14Array BioPharma To Present At The Wells Fargo Securities 2014 Healthcare ConferencePrinter Friendly Version
06/02/14Two Array-Invented MEK Inhibitors Showcased At ASCOPrinter Friendly Version
05/28/14Array BioPharma Announces Drug Discovery Collaboration Agreement With Biogen IdecPrinter Friendly Version
05/27/14Array BioPharma To Present At The Jefferies 2014 Global Healthcare ConferencePrinter Friendly Version
05/19/14Array BioPharma Announces Key Additions To Scientific LeadershipPrinter Friendly Version
05/14/14Array BioPharma Announces Clinical Data Presentations At The 2014 ASCO Annual MeetingPrinter Friendly Version
05/12/14Array BioPharma To Present At The Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare ConferencePrinter Friendly Version
04/29/14Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2014Printer Friendly Version
04/28/14Charles M. Baum, M.D., PH.D. Joins Array BioPharma Board Of DirectorsPrinter Friendly Version
04/23/14Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014Printer Friendly Version
04/23/14Binimetinib Continues To Advance In Clinical DevelopmentPrinter Friendly Version
03/03/14Array BioPharma Provides Clinical Update On ARRY-502 For Asthma At Scientific MeetingPrinter Friendly Version
02/18/14Array BioPharma To Present At The RBC Capital Markets Global Healthcare And Cowen Annual Healthcare ConferencesPrinter Friendly Version
02/06/14Array BioPharma To Present At The Leerink Swann Global Healthcare ConferencePrinter Friendly Version
02/04/14Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2014Printer Friendly Version
01/29/14Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2014 on February 4, 2014Printer Friendly Version
01/03/14Array BioPharma To Present At The Annual J.P. Morgan Healthcare ConferencePrinter Friendly Version
12/09/13Array BioPharma Provides Clinical Update On ARRY-614 For Myelodysplastic Syndromes At The 2013 American Society Of Hematology MeetingPrinter Friendly Version
12/09/13Array BioPharma Provides Clinical Update On Filanesib (ARRY-520) For Multiple Myeloma At The 2013 American Society of Hematology MeetingPrinter Friendly Version
11/21/13Array BioPharma Announces Management Team ChangePrinter Friendly Version
11/11/13Array BioPharma To Present At The Jefferies 2013 Global Healthcare And Piper Jaffray 25th Annual Healthcare ConferencesPrinter Friendly Version
11/07/13Array BioPharma To Present Clinical Data At The 2013 ASH Annual Meeting On ARRY-520 For Multiple Myeloma And ARRY-614 For Myelodysplastic SyndromesPrinter Friendly Version
10/31/13Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2014 And Announces ARRY-520 Development StrategyPrinter Friendly Version
10/28/13Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2014 On October 31, 2013Printer Friendly Version
10/22/13AstraZeneca Initiates Phase 3 Clinical Trial For Selumetinib In Non-Small Cell Lung CancerPrinter Friendly Version
09/24/13Array BioPharma to Present at the NewsMakers in the Biotech Industry ConferencePrinter Friendly Version
09/04/13Array Biopharma To Present at the Morgan Stanley Global Healthcare Conference and the Stifel Healthcare ConferencePrinter Friendly Version
08/07/13Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2013Printer Friendly Version
07/29/13Array BioPharma And Celgene Corporation Announce Strategic global R&D Collaboration To Advance Medical Innovation To Benefit PatientsPrinter Friendly Version
07/29/13Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2013 On August 7, 2013Printer Friendly Version
07/23/13ARRY-502 Meets Primary And Key Secondary Endpoints In Asthma StudyPrinter Friendly Version
07/22/13Array Biopharma To Report Top-line Results From ARRY-502 Asthma TrialPrinter Friendly Version
07/10/13Loxo Oncology And Array BioPharma Announce License And Collaboration AgreementPrinter Friendly Version
07/02/13Array BioPharma Initiates MEK162 Phase 3 MILO Study Triggering Milestone PaymentPrinter Friendly Version
07/01/13Array BioPharma To Present At The 8th Annual JMP Securities Healthcare ConferencePrinter Friendly Version
06/17/13Array BioPharma Announces Positive Interim Results From Combination Trial Of ARRY-520 With Kyprolis At The 2013 European Hematology Association CongressPrinter Friendly Version
06/13/13Array BioPharma To Present At The Wells Fargo Securities Research And Economics 2013 Healthcare ConferencePrinter Friendly Version
06/07/13Array BioPharma Announces Exercise Of Underwriters' Option To Purchase An Additional $17.25 Million Of 3.00% Convertible Senior NotesPrinter Friendly Version
06/04/13Array BioPharma Announces Pricing of Public Offering of $115 Million of Convertible Senior NotesPrinter Friendly Version
06/04/13New Date And Time For Array BioPharma Presentation At The Jefferies 2013 Global Healthcare ConferencePrinter Friendly Version
06/03/13Array BioPharma Announces Proposed Public Offering of Convertible DebtPrinter Friendly Version
06/03/13Two Array Invented MEK Inhibitors Showcased At ASCOPrinter Friendly Version
06/02/13New drug improves progression-free survival, shrinks tumors in rare cancer for first timePrinter Friendly Version
05/30/13Array BioPharma To Present At The Jefferies 2013 Global Healthcare ConferencePrinter Friendly Version
05/30/13Oncothyreon and Array Announce Collaboration to Develop and Commercialize anti-HER2 Compound ARRY-380Printer Friendly Version
05/28/13ASLAN Pharmaceuticals announces positive data with ASLAN001 in gastric cancer phase 2 studyPrinter Friendly Version
05/15/13Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual MeetingPrinter Friendly Version
05/08/13Array BioPharma to Present at the Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare ConferencePrinter Friendly Version
05/06/13Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013Printer Friendly Version
05/06/13Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian CancerPrinter Friendly Version
04/29/13Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2013 On May 6, 2013Printer Friendly Version
04/04/13Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma WorkshopPrinter Friendly Version
03/21/13Array BioPharma Names Michael N. Needle, M.D. As Chief Medical OfficerPrinter Friendly Version
03/05/13Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on HematologyPrinter Friendly Version
02/26/13Array BioPharma To Present At The Cowen Annual Health Care ConferencePrinter Friendly Version
02/08/13Array BioPharma To Present At The Leerink Swann Global Healthcare ConferencePrinter Friendly Version
02/04/13Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2013Printer Friendly Version
01/29/13Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2013 On February 4, 2013Printer Friendly Version
12/27/12Array BioPharma To Present At The Annual J.P. Morgan Healthcare ConferencePrinter Friendly Version
12/10/12Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology MeetingPrinter Friendly Version
12/05/12Array BioPharma Announces Exercise And Closing Of Underwriters' Over-Allotment OptionPrinter Friendly Version
11/15/12Array BioPharma To Present At The Piper Jaffray Annual Healthcare ConferencePrinter Friendly Version
11/09/12Array BioPharma Announces Pricing Of Public Offering Of Common StockPrinter Friendly Version
11/08/12Array BioPharma Announces Proposed Public Offering Of Common StockPrinter Friendly Version
11/08/12MEK162 Registration Path Announced Printer Friendly Version
11/07/12Array BioPharma to Present at the Lazard Annual Healthcare and Jefferies 2012 Global Healthcare ConferencesPrinter Friendly Version
11/07/12John A. Orwin Joins Array BioPharma Board Of DirectorsPrinter Friendly Version
11/06/12Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual MeetingPrinter Friendly Version
11/05/12Array BioPharma To Present Clinical Data At The 2012 ASH Meeting On ARRY-520, A KSP Inhibitor, And ARRY-614, A Dual p38/Tie2 InhibitorPrinter Friendly Version
11/01/12Array BioPharma to Hold Conference Call on Monday, November 5, 2012 to Discuss Submitted ASH AbstractsPrinter Friendly Version
10/29/12Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013Printer Friendly Version
10/23/12Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2013 On October 29, 2012Printer Friendly Version
09/11/12Array BioPharma to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
08/31/12Array BioPharma Announces Changes to Board of DirectorsPrinter Friendly Version
08/29/12Array BioPharma to Present at the Stifel Nicolaus Healthcare, NewsMakers in the Biotech Industry and Morgan Stanley Global Healthcare ConferencesPrinter Friendly Version
08/13/12Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012Printer Friendly Version
08/06/12Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 on August 13, 2012Printer Friendly Version
07/31/12Array BioPharma’s ARRY-797 Meets Primary Endpoint in Clinical Proof of Concept Trial in Osteoarthritis Patients Whose Pain is Poorly Controlled by NSAIDsPrinter Friendly Version
07/24/12Array BioPharma Names Andrew Robbins as Senior Vice President, Commercial OperationsPrinter Friendly Version
07/19/12Array BioPharma Achieves $8.5 Million Clinical Milestone in Amgen Diabetes CollaborationPrinter Friendly Version
07/16/12Clovis Oncology and Array BioPharma Announce Agreement to Discover Novel Mutant KIT InhibitorPrinter Friendly Version
07/03/12Array BioPharma to Present at the JMP Securities Healthcare Conference 2012Printer Friendly Version
06/04/12Promising Data for KRAS Mutant Advanced NSCLC Patients Presented at ASCOPrinter Friendly Version
06/04/12MEK162 Shows Promising Clinical Activity in Ongoing Phase 2 TrialPrinter Friendly Version
05/30/12Array BioPharma to Present at the Jefferies 2012 Global Healthcare ConferencePrinter Friendly Version
05/16/12Array BioPharma Announces Clinical Data Presentations at the 2012 ASCO Annual MeetingPrinter Friendly Version
05/14/12Array BioPharma and Genentech's Strategic Alliance Voted Breakthrough Alliance of 2012Printer Friendly Version
04/30/12Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2012Printer Friendly Version
04/30/12Array BioPharma Names Liam Ratcliffe, M.D., Ph.D., to Board of DirectorsPrinter Friendly Version
04/26/12Array BioPharma Names Ron Squarer Chief Executive OfficerPrinter Friendly Version
04/23/12Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2012 on April 30, 2012Printer Friendly Version
04/16/12Array BioPharma Names Howard Holden, Ph.D., Vice President of Regulatory Affairs and Quality AssurancePrinter Friendly Version
04/04/12Encouraging Selumetinib Results Announced for Phase 2 Trial in Ovarian CancerPrinter Friendly Version
03/31/12Selumetinib Controlled Recurrent Low-grade Serous Ovarian CancerPrinter Friendly Version
02/27/12Array BioPharma to Present at the Cowen and Company 32nd Annual Health Care ConferencePrinter Friendly Version
02/14/12Array BioPharma Announces Closing of Public Offering of Common Stock and Exercise of Overallotment OptionPrinter Friendly Version
02/09/12Array BioPharma to Present at the Leerink Swann Global Healthcare ConferencePrinter Friendly Version
02/08/12Array BioPharma Announces Proposed Public Offering of Common StockPrinter Friendly Version
01/30/12Array BioPharma Names Gwen A. Fyfe, M.D. to Board of DirectorsPrinter Friendly Version
01/30/12Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2012Printer Friendly Version
01/23/12Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2012 on January 30, 2012Printer Friendly Version
01/16/12Array BioPharma's Chief Executive Officer Robert E. Conway ResignsPrinter Friendly Version
01/04/12Array BioPharma to Present at the 30th Annual J.P. Morgan Healthcare ConferencePrinter Friendly Version
12/11/11ARRY-614 Demonstrates Positive Single Agent Activity in Patients with Myelodysplastic SyndromesPrinter Friendly Version
12/11/11ARRY-520 Demonstrates Durable Single-Agent Activity in Patients with Advanced Multiple MyelomaPrinter Friendly Version
12/01/11Array BioPharma to Host Analyst and Investor Day Featuring Distinguished Clinical InvestigatorsPrinter Friendly Version
11/29/11Array Biopharma to Present Clinical Data on ARRY-520, a KSP Inhibitor, and ARRY-614, a Dual p38/Tie2 Inhibitor, at the 2011 American Society of Hematology Annual MeetingPrinter Friendly Version
11/17/11Array BioPharma to Present at the Piper Jaffray Health Care ConferencePrinter Friendly Version
10/31/11Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2012Printer Friendly Version
10/24/11Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2012 on October 31, 2011Printer Friendly Version
09/30/11Topline Results:A Randomized Phase 2 Study of Selumetinib in Patients with KRAS-Mutant Non-Small Cell Lung CancerPrinter Friendly Version
09/13/11Array BioPharma to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
09/08/11Array BioPharma Names Karsten Witt, M.D., Vice President of Clinical SciencesPrinter Friendly Version
08/29/11Array BioPharma to Present at the Stifel Nicolaus Healthcare Conference and the Rodman & Renshaw Global Investment ConferencePrinter Friendly Version
08/08/11Array BioPharma Reports Results for the Fourth Quarter and Full Year of Fiscal 2011Printer Friendly Version
08/08/11Array Announces New Oncology Agreement with GenentechPrinter Friendly Version
08/04/11Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2011 on August 8, 2011Printer Friendly Version
07/13/11Array BioPharma Licenses Cancer Drug ARRY-543 to ASLAN PharmaceuticalsPrinter Friendly Version
06/13/11Array BioPharma Announces RestructuringPrinter Friendly Version
05/31/11Array BioPharma to Present at the Jefferies 2011 Global HealthcareConferencePrinter Friendly Version
05/02/11Array BioPharma Announces $30 Million Debt Reduction and a Loan Term Extension to 2015 and 2016Printer Friendly Version
05/02/11Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2011Printer Friendly Version
04/25/11Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2011 on May 2, 2011Printer Friendly Version
04/07/11Array BioPharma Achieves $10 Million Clinical Milestone in MEK162 Oncology ProgramPrinter Friendly Version
04/01/11Array BioPharma Announces Five Abstracts Selected for Presentation at 2011 AACR Annual MeetingPrinter Friendly Version
03/29/11Array BioPharma to Present at the Leerink Swann Cancer RoundtableConferencePrinter Friendly Version
03/08/11Array BioPharma to Present at the Roth 23rd Annual OC Growth Stock Conference and the Barclay's Capital 2011 Global Healthcare ConferencePrinter Friendly Version
02/28/11Array BioPharma to Present at the Cowen and Company 31st Annual Health Care ConferencePrinter Friendly Version
01/31/11Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2011Printer Friendly Version
01/24/11Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2011 on January 31, 2011Printer Friendly Version
01/04/11Array BioPharma to Present at the 29th Annual J.P. Morgan Healthcare ConferencePrinter Friendly Version
12/04/10Array BioPharma's Arry-520 Demonstrates Single Agent Activity in Advanced Multiple Myeloma Patients Printer Friendly Version
11/30/10Array BioPharma Achieves Clinical Milestone in Celgene CollaborationPrinter Friendly Version
11/29/10Array BioPharma to Present ARRY-520 / KSP Inhibitor Data at2010 ASH Annual MeetingPrinter Friendly Version
11/16/10Array BioPharma to Present at the 22nd Annual Piper Jaffray Health Care ConferencePrinter Friendly Version
11/11/10Array BioPharma to Present at the Lazard Capital Markets 7th Annual Healthcare ConferencePrinter Friendly Version
11/08/10Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2011Printer Friendly Version
11/02/10Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2011 on November 8, 2010Printer Friendly Version
10/01/10Array BioPharma Announces Positive Results for HER2 Inhibitor, ARRY-380, in Breast Cancer Patients Printer Friendly Version
09/13/10Array BioPharma to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
09/07/10Array BioPharma to Present at the Rodman & Renshaw Global Investment Conference and the Stifel Nicolaus Healthcare ConferencePrinter Friendly Version
08/09/10Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2010Printer Friendly Version
08/03/10Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2010 on August 9, 2010Printer Friendly Version
06/05/10Array BioPharma's ARRY-520Well Tolerated and Demonstrates Preliminary Activity as a Single Agent in Multiple Myeloma PatientsPrinter Friendly Version
06/01/10Array BioPharma to Present at the Jefferies 2010 Global Life Sciences ConferencePrinter Friendly Version
05/20/10Array BioPharma Announces Abstracts Selected for Presentation at 2010 ASCO Annual MeetingPrinter Friendly Version
05/03/10Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2010Printer Friendly Version
04/26/10Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2010 on May 3, 2010Printer Friendly Version
04/19/10Array BioPharma Signs Strategic Oncology CollaborationPrinter Friendly Version
04/12/10Array BioPharma Announces Eight Abstracts Selected for Presentation at 2010 AACR Annual MeetingPrinter Friendly Version
02/01/10Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2010Printer Friendly Version
02/01/10Array BioPharma to Present at the 12th Annual BIO CEO & Investor ConferencePrinter Friendly Version
01/26/10Array BioPharma Names Bengt Bergstrom, M.D., Ph.D., Vice President, Clinical DevelopmentPrinter Friendly Version
01/25/10Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2010 on February 1, 2010Printer Friendly Version
01/04/10Array BioPharma to Present at the JP Morgan 28th Annual Healthcare ConferencePrinter Friendly Version
12/14/09Array BioPharma and Amgen Partner in Type 2 DiabetesPrinter Friendly Version
12/12/09Array BioPharma Announces Positive Interim Results for Phase 1 Study of Its HER2 Inhibitor, ARRY-380, in Cancer PatientsPrinter Friendly Version
11/23/09Array BioPharma to Present at the Piper Jaffray Healthcare ConferencePrinter Friendly Version
11/02/09Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2010Printer Friendly Version
10/28/09Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2010 on November 2, 2009Printer Friendly Version
10/01/09Array BioPharma to Present Clinical Results on Diabetes Drug at European Diabetes MeetingPrinter Friendly Version
09/18/09Array BioPharma Enters into Equity Distribution Agreement Printer Friendly Version
09/15/09Array BioPharma to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
09/03/09Array BioPharma Announces Top-Line Results from Rheumatoid Arthritis Phase 2 TrialPrinter Friendly Version
09/02/09Array BioPharma to Present at the Baird 2009 Healthcare Conference and the Thomas Weisel Partners 2009 Healthcare ConferencePrinter Friendly Version
08/10/09Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2009Printer Friendly Version
08/10/09Array BioPharma Reports Positive Results of Its Oral Glucokinase Activator in Type 2 Diabetes PatientsPrinter Friendly Version
08/05/09Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2009 on August 10, 2009Printer Friendly Version
07/15/09Array BioPharma Advances Its Lead MEK Inhibitor into CancerPrinter Friendly Version
07/08/09Array BioPharma Announces Top-Line Results in Two Phase 1 Clinical TrialsPrinter Friendly Version
06/11/09Array BioPharma to Present at the Jefferies 3rd Annual Healthcare ConferencePrinter Friendly Version
06/02/09Array BioPharma Recognized by CIO Magazine as One of the CIO 100 Award HonoreesPrinter Friendly Version
05/19/09Array BioPharma Receives Additional $40 Million Funding CommitmentPrinter Friendly Version
05/12/09Array BioPharma to Present at Leerink Swann Oncology Roundtable ConferencePrinter Friendly Version
05/04/09Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2009Printer Friendly Version
04/29/09Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2009 on May 4, 2009Printer Friendly Version
04/21/09Array BioPharma's ARRY-520 Demonstrates Significant Activity in Hematological and Taxane-Resistant TumorsPrinter Friendly Version
04/21/09Array BioPharma Presents Initial Data on Novel Class of Chk1 InhibitorsPrinter Friendly Version
04/21/09Array BioPharma's ARRY-543 Shows Potential Clinical Benefit in Cancer PatientsPrinter Friendly Version
04/19/09Array BioPharma's ARRY-614 Demonstrates Cytokine Inhibition and Anti-Tumor Activity in Preclinical Models of Hematological CancersPrinter Friendly Version
04/08/09Array BioPharma Initiates Clinical Trial in Type 2 Diabetic PatientsPrinter Friendly Version
04/06/09Array BioPharma Announces Eighteen Abstracts Selected for Presentation at 2009 AACR Annual MeetingPrinter Friendly Version
03/03/09Array BioPharma to Present at the Barclays Capital Global HealthCare ConferencePrinter Friendly Version
02/02/09Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2009Printer Friendly Version
02/02/09Array BioPharma to Present at the BIO CEO & Investor ConferencePrinter Friendly Version
01/26/09Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2009 on February 2, 2009Printer Friendly Version
01/09/09Array BioPharma Accelerates Partnering Activities and Scales Back Discovery Research to Extend Available CapitalPrinter Friendly Version
01/09/09Array BioPharma Initiates Phase 1 Clinical Trial for MEK Inhibitor ARRY-300Printer Friendly Version
12/23/08Array BioPharma Receives $40 Million from DeerfieldPrinter Friendly Version
12/16/08Array BioPharma to Present at the JP Morgan 27th Annual Healthcare ConferencePrinter Friendly Version
11/20/08Array BioPharma to Present at the Piper Jaffray Health Care ConferencePrinter Friendly Version
11/07/08Array BioPharma Inc. Files Shelf Registration StatementPrinter Friendly Version
11/03/08Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2009Printer Friendly Version
10/27/08Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2009 on November 3, 2008Printer Friendly Version
10/26/08Array BioPharma's Oral p38 Inhibitor Demonstrates Significant Analgesic Benefit and Systemic Anti-Inflammatory ActivityPrinter Friendly Version
10/20/08Array BioPharma to Present Clinical Data at the 2008 ACR/ARHP Annual Scientific MeetingPrinter Friendly Version
09/29/08Array BioPharma to Present at the William Blair Small-Cap Growth Stock ConferencePrinter Friendly Version
09/25/08Array BioPharma Presents Positive Preclinical Data on Its Glucokinase Activators in Type 2 DiabetesPrinter Friendly Version
09/16/08Array BioPharma to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
09/02/08Array BioPharma to Present at the Morgan Stanley Global Healthcare Unplugged Conference and the Baird Small Cap Healthcare ConferencePrinter Friendly Version
08/27/08Array BioPharma to Present at the Thomas Weisel Partners 2008 Healthcare ConferencePrinter Friendly Version
08/11/08Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2008Printer Friendly Version
07/30/08Array BioPharma to Present at the Bank of America 2008 Specialty Pharmaceuticals ConferencePrinter Friendly Version
07/28/08Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2008 on August 11, 2008Printer Friendly Version
06/30/08Array BioPharma to Present at the Collins Stewart 4th Annual Growth ConferencePrinter Friendly Version
06/16/08Array BioPharma to Present at the Jefferies 2nd Annual Healthcare ConferencePrinter Friendly Version
06/12/08Array BioPharma Presents Additional Positive Phase 1 Results in Two Programs at the 2008 Annual European Congress of RheumatologyPrinter Friendly Version
06/10/08Array BioPharma to Present Clinical Data at the 2008 Annual European Congress of RheumatologyPrinter Friendly Version
06/09/08Array BioPharma to Present at the Jefferies 2nd Annual Healthcare ConferencePrinter Friendly Version
05/16/08Array BioPharma to Present at the Citi 2008 Global Healthcare ConferencePrinter Friendly Version
05/15/08Array BioPharma and AstraZeneca Announce New Phase 2 Development Plans for the Investigational Anti-Cancer Drug AZD6244 (ARRY-886)Printer Friendly Version
05/08/08 Array BioPharma to Present at the Bank of America Securities Healthcare ConferencePrinter Friendly Version
05/07/08Array BioPharma Presents Additional Positive Phase 2 Results in Inflammatory Pain Clinical Trial at the American Pain Society's Annual Scientific MeetingPrinter Friendly Version
05/05/08Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2008Printer Friendly Version
05/05/08Array BioPharma Receives $80 Million Funding CommitmentPrinter Friendly Version
05/05/08Array BioPharma to Present at Leerink Swann ConferencePrinter Friendly Version
04/30/08Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2008 on May 5, 2008Printer Friendly Version
03/25/08Array BioPharma Advances p38 / Tie2 Inhibitor, ARRY-614, into Phase 1 Clinical TrialPrinter Friendly Version
03/18/08Array BioPharma Names Gary M. Clark, Ph.D., Vice President, Biostatistics and Data ManagementPrinter Friendly Version
03/13/08Array BioPharma to Present at the Lehman Brothers Global Healthcare ConferencePrinter Friendly Version
03/03/08Array BioPharma to Present at the Susquehanna Healthcare ConferencePrinter Friendly Version
03/03/08Array BioPharma Announces Positive Phase 2 Top-Line Results in Inflammatory Pain Clinical TrialPrinter Friendly Version
02/06/08Array BioPharma to Present at the 2008 BIO CEO & Investor ConferencePrinter Friendly Version
02/04/08Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2008Printer Friendly Version
01/31/08Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2008 on February 4, 2008Printer Friendly Version
01/03/08Array BioPharma to Present at the 26th Annual JPMorgan Healthcare ConferencePrinter Friendly Version
12/19/07Topline Results Announced from a Phase 2 Study in Advanced Melonoma of Investigational Anti-Cancer Drug AZD6244 (ARRY-886)Printer Friendly Version
11/20/07Array BioPharma to Present at the 19th Annual Piper Jaffray Health Care ConferencePrinter Friendly Version
11/20/07Array BioPharma Advances p38 Inhibitor, ARRY-797, into Phase 2 Clinical TrialPrinter Friendly Version
11/05/07Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2008Printer Friendly Version
10/31/07Array BioPharma to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare ConferencePrinter Friendly Version
10/31/07Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2008 on November 5, 2007Printer Friendly Version
10/24/07Array BioPharma Reports Positive New Data on ErbB-2 / EGFR Inhibitor, ARRY-543Printer Friendly Version
10/22/07Array BioPharma to Present Clinical Data at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsPrinter Friendly Version
09/24/07Array BioPharma and Celgene Corporation Announce Strategic Global R&D CollaborationPrinter Friendly Version
09/17/07Array BioPharma to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
08/29/07Array BioPharma to Present at the Thomas Weisel Partners Healthcare ConferencePrinter Friendly Version
08/06/07Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2007Printer Friendly Version
08/03/07Array BioPharma Advances ErbB-2 Inhibitor, ARRY-380, into Phase 1 Cancer Patient TrialPrinter Friendly Version
08/02/07Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2007 on August 6, 2007Printer Friendly Version
07/05/07Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth ConferencePrinter Friendly Version
06/21/07Array BioPharma to Present at the Jefferies Healthcare ConferencePrinter Friendly Version
06/20/07Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory DrugsPrinter Friendly Version
06/06/07Array BioPharma to Present at the Needham Biotechnology & Medical Technology ConferencePrinter Friendly Version
05/30/07Array BioPharma to Present Clinical Data at the European League Against Rheumatism (EULAR) Annual Meeting and the 8th World Congress on InflammationPrinter Friendly Version
05/23/07Array BioPharma to Present at the Banc of America Securities Healthcare ConferencePrinter Friendly Version
05/15/07Array BioPharma Appoints John Yates, MB ChB, MD, to Chief Medical OfficerPrinter Friendly Version
05/08/07Array BioPharma Appoints Dr. Jonathan Kay to Its Scientific Advisory Board for Inflammation TherapyPrinter Friendly Version
05/03/07Array BioPharma Initiates Phase 1 Clinical Trial for Anticancer KSP Inhibitor ARRY-520Printer Friendly Version
05/01/07Array BioPharma Inc. Announces Pricing of Proposed Public Offering of Common StockPrinter Friendly Version
04/23/07Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2007Printer Friendly Version
04/23/07Array BioPharma Inc. Announces Proposed Public Offering of Common StockPrinter Friendly Version
04/18/07Array BioPharma Appoints Dr. Neil Spector to Its Scientific Advisory BoardPrinter Friendly Version
04/12/07Array BioPharma Achieves Milestone for Dosing MEK Inhibitor, ARRY-704, in Phase 1 Clinical TrialPrinter Friendly Version
04/10/07Array BioPharma Advances p38 Inhibitor, ARRY-797, into Phase 1 Cancer Patient TrialPrinter Friendly Version
03/14/07Array BioPharma to Present at the Lehman Brothers Annual Global Healthcare ConferencePrinter Friendly Version
03/13/07Array BioPharma and VentiRx Pharmaceuticals Announce License AgreementPrinter Friendly Version
02/06/07Array BioPharma to Present at the BIO CEO & Investor ConferencePrinter Friendly Version
02/05/07Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2007Printer Friendly Version
01/30/07Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2007 on February 5, 2007Printer Friendly Version
12/28/06Array BioPharma's KSP Inhibitor for Cancer to Advance into Human Clinical TrialsPrinter Friendly Version
12/22/06Array BioPharma to Present at the 25th Annual JPMorgan Healthcare ConferencePrinter Friendly Version
11/28/06Array BioPharma Announces Analyst Event and Live Webcast in New York CityPrinter Friendly Version
11/21/06Array BioPharma to Present at the Piper Jaffray Health Care ConferencePrinter Friendly Version
11/08/06Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers: phase II trials initiatedPrinter Friendly Version
11/06/06Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2007Printer Friendly Version
11/06/06Array BioPharma Announces Clinical Trial Data With AZD6244 (ARRY-142886) To Be Presented at the 2006 EORTC-NCI-AACR International MeetingPrinter Friendly Version
10/31/06Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2007 on November 6, 2006Printer Friendly Version
10/31/06Array BioPharma's p38 Inhibitor for Inflammatory Disease to Advance into Human Clinical TrialsPrinter Friendly Version
10/23/06Array BioPharma to Present at the C.E. Unterberg, Towbin Life Sciences ConferencePrinter Friendly Version
10/19/06Array BioPharma Reports MEK Inhibitor, ARRY-438162, Meets Initial Clinical ObjectivesPrinter Friendly Version
10/06/06Array BioPharma Inc. Files Shelf Registration StatementPrinter Friendly Version
10/03/06Array BioPharma to Present Inflammation Pipeline at the 14th International IRA ConferencePrinter Friendly Version
09/14/06Array BioPharma Receives Phase 2 Milestone Payment From AstraZenecaPrinter Friendly Version
09/14/06Array BioPharma to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
09/14/06Array BioPharma to Present at the Leerink Swann & Company Cancer Medicines on the Horizon ConferencePrinter Friendly Version
08/28/06Array BioPharma to Present at the Thomas Weisel Partners Healthcare ConferencePrinter Friendly Version
08/28/06Array BioPharma to Present at the Roth Capital Partners 2006 New York ConferencePrinter Friendly Version
08/10/06Array BioPharma Receives $14 Million From Longmont Facilities TransactionPrinter Friendly Version
08/07/06Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2006Printer Friendly Version
08/01/06Array BioPharma to Present at the 26th Annual Canaccord Adams Summer SeminarPrinter Friendly Version
07/31/06Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2006 on August 7, 2006Printer Friendly Version
07/11/06Array BioPharma Receives $18 Million From Boulder Facilities TransactionPrinter Friendly Version
07/06/06Array BioPharma to Present at the C.E. Unterberg, Towbin Emerging Growth ConferencePrinter Friendly Version
06/22/06Array BioPharma to Obtain $32 Million in Additional Cash From Facilities TransactionsPrinter Friendly Version
06/20/06Array BioPharma to Present at the Jefferies Life Sciences ConferencePrinter Friendly Version
06/08/06AstraZeneca and Array BioPharma Announce Initiation of Phase II Studies for AZD6244 (ARRY-142886)Printer Friendly Version
06/05/06Array BioPharma to Present at the Needham Annual Biotechnology & Medical Technology ConferencePrinter Friendly Version
05/01/06Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2006Printer Friendly Version
04/26/06Array BioPharma Initiates Phase 1 Clinical Trial of Its MEK Inhibitor for Inflammatory DiseasePrinter Friendly Version
04/25/06Array Biopharma to Report Financial Results for the Third Quarter of Fiscal 2006 on May 1, 2006Printer Friendly Version
04/17/06Array BioPharma Achieves Research Milestone in Genentech CollaborationPrinter Friendly Version
04/10/06Array BioPharma Achieves Milestone for Selection of Third Compound for MEK Anti-Cancer ProgramPrinter Friendly Version
03/14/06Array BioPharma Announces KSP Anti-Cancer ProgramPrinter Friendly Version
02/08/06Array BioPharma to Present at the Roth Capital Partners Annual Growth Stock ConferencePrinter Friendly Version
02/06/06Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2006Printer Friendly Version
02/01/06Array BioPharma to Present at the BIO CEO & Investor Conference 2006Printer Friendly Version
01/30/06Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2006 on February 6, 2006Printer Friendly Version
01/24/06Array BioPharma Achieves Milestone for Selection of Second Clinical Candidate for MEK Anti-Cancer ProgramPrinter Friendly Version
01/17/06Array BioPharma Initiates Phase I Clinical Trial for Targeted Anticancer Drug ARRY-334543Printer Friendly Version
12/13/05Co-Founder of Array BioPharma to Lead New Korean Out-Sourcing Chemistry CompanyPrinter Friendly Version
11/08/05Array BioPharma to Present Phase IA Data From Anti-Cancer Compound at the AACR-NCI-EORTC International Conference On Molecular Targets And Cancer TherapeuticsPrinter Friendly Version
11/03/05Array BioPharma Announces Drug Discovery Collaboration With Ono Pharmaceutical Co., Ltd.Printer Friendly Version
10/31/05Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2006Printer Friendly Version
10/24/05Array BioPharma to Report Financial Results for the First Quarter Fiscal 2006 on October 31, 2005Printer Friendly Version
10/13/05Array BioPharma and Genentech Expand Strategic Oncology CollaborationPrinter Friendly Version
09/19/05Array BioPharma to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
08/31/05Array BioPharma to Present at the Thomas Weisel Partners Healthcare Conference 2005Printer Friendly Version
08/08/05Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2005Printer Friendly Version
08/08/05Array BioPharma's Anticancer Compound ARRY-334543 Cleared to Advance Into Human Clinical TrialsPrinter Friendly Version
08/05/05Array BioPharma Amends Facility LeasePrinter Friendly Version
08/04/05Array BioPharma Announces Lease RestatementPrinter Friendly Version
08/03/05Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2005 on August 8, 2005Printer Friendly Version
07/19/05InterMune and Array BioPharma Expand Hepatitis C Drug Discovery CollaborationPrinter Friendly Version
05/18/05Array BioPharma to Present at the Fourth Annual Needham Biotechnology ConferencePrinter Friendly Version
05/12/05Array BioPharma to Present Data From Anti-Cancer Program at the American Society of Clinical Oncology Annual MeetingPrinter Friendly Version
05/10/05Array BioPharma Receives Milestone Payment From AmgenPrinter Friendly Version
05/09/05Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2005Printer Friendly Version
05/04/05Array BioPharma to Present at the Banc of America Securities Health Care Conference 2005Printer Friendly Version
05/02/05Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2005 on May 9, 2005Printer Friendly Version
04/18/05Array BioPharma Presents Data on Two Cancer Programs at the 96th Annual Meeting of the American Association for Cancer ResearchPrinter Friendly Version
04/07/05Array BioPharma and Genentech Expand Oncology CollaborationPrinter Friendly Version
02/15/05Array BioPharma to Present at the BIO CEO & Investor Conference 2005Printer Friendly Version
02/08/05Reminder - Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2005 on February 7, 2005Printer Friendly Version
02/07/05Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2005Printer Friendly Version
01/31/05Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2005 on February 7, 2005Printer Friendly Version
01/18/05Array BioPharma to Present at the Piper Jaffray Health Care ConferencePrinter Friendly Version
12/14/04Array BioPharma Announces Exercise of Over-Allotment Option and Completion Of Common Stock OfferingPrinter Friendly Version
12/09/04Array BioPharma Announces Pricing of a Public Offering of 8,000,000 Shares of Common StockPrinter Friendly Version
12/07/04Array BioPharma Grants InterMune Expanded Rights Under Hepatitis C Discovery AgreementPrinter Friendly Version
11/30/04Array BioPharma Announces Offering of Common StockPrinter Friendly Version
11/01/04Array Biopharma Reports Financial Results for the First Quarter of Fiscal 2005Printer Friendly Version
11/01/04Intermune Announces Presentation of Data on Potent HCV Protease Inhibitor Drug CandidatesPrinter Friendly Version
10/27/04Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2005 On November 1, 2004Printer Friendly Version
10/21/04Array Biopharma to Present at the Bio-Europe 2004 Partnering ConferencePrinter Friendly Version
10/05/04Array BioPharma Appoints Ronald B. Franklin, Ph.D., D.A.B.T Senior Director Drug MetabolismPrinter Friendly Version
10/04/04Array BioPharma to Present at the BIO Emerging Company Investor ForumPrinter Friendly Version
09/14/04Array CEO Robert E. Conway to Speak at the UBS Global Life Sciences ConferencePrinter Friendly Version
08/25/04Array CEO Robert E. Conway to Speak at the Thomas Weisel Partners Healthcare Tailwinds 2004 ConferencePrinter Friendly Version
08/10/04Array BioPharma and QLT Announce Drug Discovery Collaboration Focused on CancerPrinter Friendly Version
08/02/04Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2004Printer Friendly Version
07/27/04Array BioPharma To Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2004 on August 2, 2004Printer Friendly Version
06/14/04Array BioPharma Achieves Milestone for Initiation of Phase I Clinical Trial for Anticancer Compound ARRY-142886Printer Friendly Version
06/09/04Array CEO Robert E. Conway to Speak at the Third Annual Needham Biotechnology ConferencePrinter Friendly Version
06/03/04Trimeris and Array BioPharma Extend Antiviral Drug Discovery AgreementPrinter Friendly Version
06/02/04Array CEO Robert E. Conway to Speak at the BIO 2004 Business ForumPrinter Friendly Version
06/01/04Array BioPharma Receives Milestone Payment From AmgenPrinter Friendly Version
05/25/04Array CEO Robert E. Conway to Speak at the Friedman Billings Ramsey 8th Annual Growth Investor ConferencePrinter Friendly Version
05/06/04Array CEO Robert E. Conway to Speak at the Banc of America Securities Health Care ConferencePrinter Friendly Version
05/03/04Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2004Printer Friendly Version
04/29/04Array BioPharma Appoints Douglas E. Williams, Ph.D., to Its Board of DirectorsPrinter Friendly Version
04/27/04Array BioPharma To Report Financial Results for the Third Quarter of Fiscal 2004 on May 3, 2004Printer Friendly Version
04/22/04Array BioPharma Inc. Files Shelf Registration StatementPrinter Friendly Version
04/05/04Array BioPharma Announces Drug Discovery Collaboration With Takeda Chemical Industries, Ltd.Printer Friendly Version
04/01/04Reminder - Array CEO Robert E. Conway to Speak at the Future Leaders in the Biotech Industry ConferencePrinter Friendly Version
03/27/04Investigational MEK Inhibitor, ARRY-142886 (AZD6244), Combats Cancer GrowthPrinter Friendly Version
03/19/04Array BioPharma President Kevin Koch to Present at American Association for Cancer Research MeetingPrinter Friendly Version
03/16/04Array CEO Robert E. Conway to Speak at the Future Leaders in the Biotech Industry ConferencePrinter Friendly Version
03/05/04Array BioPharma's Anticancer Compound ARRY-142886 Cleared to Advance Into Human Clinical TrialsPrinter Friendly Version
02/19/04Array BioPharma Appoints Drs. S. Gail Eckhardt And Randall K. Johnson to Its Scientific Advisory BoardPrinter Friendly Version
02/10/04Array CEO Robert E. Conway to Speak at BIO CEO & Investor ConferencePrinter Friendly Version
02/02/04Array BioPharma Reports Financial Results for the Second Quarter Of Fiscal 2004Printer Friendly Version
01/27/04Array BioPharma To Report Financial Results for the Second Quarter of Fiscal 2004 on February 2, 2004Printer Friendly Version
01/05/04Array BioPharma Announces Oncology Collaboration With GenentechPrinter Friendly Version
12/18/03Array BioPharma and AstraZeneca Announce Oncology CollaborationPrinter Friendly Version
11/03/03Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2004Printer Friendly Version
10/28/03Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2004 on November 3, 2003Printer Friendly Version
09/09/03Array CEO Robert E. Conway to Speak at the UBS Warburg Global Life Sciences ConferencePrinter Friendly Version
08/21/03Array CEO Robert E. Conway to Speak at the Thomas Weisel Partners' Healthcare Tailwinds 2003 ConferencePrinter Friendly Version
08/04/03Array BioPharma Reports Financial Results for the Fourth Quarter And Full Year of Fiscal 2003Printer Friendly Version
07/29/03Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2003 On August 4, 2003Printer Friendly Version
07/07/03GenPath and Array BioPharma Announce Drug Discovery Collaboration Focused on CancerPrinter Friendly Version
06/17/03Updated Speaking Time - Array CEO Robert E. Conway to Speak at the BIO 2003 Annual Convention Business ForumPrinter Friendly Version
06/11/03Array CEO Robert E. Conway to Speak at the BIO 2003 Annual Convention Business ForumPrinter Friendly Version
05/22/03Array CEO Robert E. Conway to Speak at Needham & Company Biotechnology ConferencePrinter Friendly Version
05/05/03Array BioPharma Reports Financial Results For the Third Quarter of Fiscal 2003Printer Friendly Version
04/28/03Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2003 on May 5, 2003Printer Friendly Version
03/31/03Array BioPharma Lowers Revenue ForecastPrinter Friendly Version
02/25/03Array CEO Robert E. Conway To Speak at Lehman Brothers Healthcare ConferencePrinter Friendly Version
02/11/03Array CEO Robert E. Conway to Speak at BIO CEO & Investor ConferencePrinter Friendly Version
02/03/03Array BioPharma Reports Financial Results For The Second Quarter of Fiscal 2003Printer Friendly Version
01/27/03Array BioPharma To Report Financial Results for the Second Quarter of Fiscal 2003 On February 3, 2003Printer Friendly Version
01/21/03Array CEO Robert E. Conway to Speak at UBS Warburg Global Healthcare Services ConferencePrinter Friendly Version
12/19/02Array BioPharma Adjusts Growth Expectations for Fiscal 2003Printer Friendly Version
11/04/02Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2003Printer Friendly Version
10/31/02Array BioPharma Appoints Gil Van Lunsen From KPMG to Its Board of DirectorsPrinter Friendly Version
10/28/02Array BioPharma To Report Financial Results for the First Quarter of Fiscal 2003 On November 4, 2002Printer Friendly Version
09/30/02InterMune and Array BioPharma Announce Drug Discovery Collaboration Focused on HepatitisPrinter Friendly Version
09/23/02Array CEO Robert E. Conway to Speak At UBS Warburg Global Life Sciences ConferencePrinter Friendly Version
08/05/02Array BioPharma Reports Financial Results For The Fourth Quarter and Full Year of Fiscal 2002Printer Friendly Version
07/30/02Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2002 On August 5, 2002Printer Friendly Version
05/22/02Array CEO Robert E. Conway to Speak At Needham & Company Biotechnology ConferencePrinter Friendly Version
05/14/02Array BioPharma Appoints James D. Winkler, Ph.D. Discovery Biology DirectorPrinter Friendly Version
05/13/02Array BioPharma Added to Nasdaq Biotechnology IndexPrinter Friendly Version
05/06/02Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2002Printer Friendly Version
05/01/02Array BioPharma Appoints John R. Moore General CounselPrinter Friendly Version
04/26/02Array CEO Robert E. Conway to Speak at Deutsche Bank Securities Health Care ConferencePrinter Friendly Version
04/25/02Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2002 on May 6, 2002Printer Friendly Version
04/22/02Callisto, Array BioPharma In Collaboration Printer Friendly Version
04/05/02Aptus and Array BioPharma Announce Drug Discovery Collaboration; Small Molecule Drug Discovery Agreement Targets GPCRsPrinter Friendly Version
03/13/02Array BioPharma Announces Drug Discovery Collaboration With Japan TobaccoPrinter Friendly Version
02/27/02Array BioPharma Announces Exercise of Over-Allotment Option in Public OfferingPrinter Friendly Version
02/19/02Array CEO Robert E. Conway to Speak At Bio CEO & Investor Conference and Lehman Brothers Healthcare ConferencePrinter Friendly Version
02/19/02Array BioPharma to Expand Laboratory SpacePrinter Friendly Version
02/14/02Array BioPharma Schedules Conference Call to Provide Financial GuidancePrinter Friendly Version
02/13/02Array BioPharma Announces Pricing of Stock OfferingPrinter Friendly Version
01/22/02Array BioPharma Reports Financial Results For The Second Quarter of Fiscal 2002Printer Friendly Version
01/18/02Array BioPharma to Report Financial Results For The Second Quarter of Fiscal 2002 on January 22, 2002Printer Friendly Version
01/16/02Array BioPharma Files Registration Statement For Public Offering of Common StockPrinter Friendly Version
01/15/02Array BioPharma Announces Compound Acquisition Agreements With PfizerPrinter Friendly Version
01/14/02Array BioPharma Initiates a New Drug Discovery Program With AmgenPrinter Friendly Version
11/15/01Array CEO Robert E. Conway to Speak at Robertson Stephens Medical Conference On Thursday, November 29, 2001Printer Friendly Version
11/05/01Array BioPharma Reports Financial Results For the First Quarter of Fiscal 2002Printer Friendly Version
10/29/01Array BioPharma to Report Financial Results for the First Quarter Of Fiscal 2002 on November 5, 2001Printer Friendly Version
10/02/01Array CEO Robert E. Conway to Speak at UBS Warburg Global Life Sciences Conference on Monday, October 8, 2001Printer Friendly Version
09/20/01Array BioPharma Announces Drug Discovery Deal With Takeda Chemical Industries, LtdPrinter Friendly Version
09/05/01Array BioPharma and Vertex Pharmaceuticals Establish Drug Discovery Agreement; Collaboration to Focus on Discovering Novel Drugs Targeting PhosphatasesPrinter Friendly Version
08/14/01Array and ICOS Establish Drug Discovery Collaboration Exploiting A Novel Chemical Proteomics PlatformPrinter Friendly Version
08/06/01Array BioPharma Reports Financial Results for the Fourth Quarter And Full Year of Fiscal 2001Printer Friendly Version
08/06/01Array BioPharma Accelerates Drug Discovery With State-of-the-Art Electronic Information SystemPrinter Friendly Version
08/06/01Trimeris And Array Biopharma Sign Antiviral Drug Discovery AgreementPrinter Friendly Version
08/03/01Array BioPharma Inc. Board Adopts Stockholder Rights PlanPrinter Friendly Version
07/31/01Array BioPharma to Report Financial Results for the Fourth Quarter And Full Year of Fiscal 2001 on August 6, 2001Printer Friendly Version
05/07/01Array BioPharma Reports Financial Results for the Third Quarter And the First Nine Months of Fiscal 2001Printer Friendly Version
05/02/01Array BioPharma Inc. to Report Third Quarter Earnings For Fiscal Year 2001 on May 7th, 2001Printer Friendly Version
04/04/01Array BioPharma to Triple Laboratory Space Over Next Four YearsPrinter Friendly Version
02/05/01Array BioPharma Reports Financial Results for the Second Quarter And the First Six Months of Fiscal 2001Printer Friendly Version
02/01/01Array BioPharma Inc. to Report Second Quarter Earnings for Fiscal Year 2001 On February 5th, 2001Printer Friendly Version
01/04/01Array BioPharma Appoints John L. Zabriskie Ph.D. to Its Board of DirectorsPrinter Friendly Version
12/07/00Array BioPharma Announces Exercise of Over-Allotment Option In Initial Public OfferingPrinter Friendly Version
11/17/00Array BioPharma Announces Initial Public OfferingPrinter Friendly Version
11/01/00Array Announces Drug Discovery Collaboration with AmgenPrinter Friendly Version
10/03/00Array Biopharma Announces Library Agreement with ImmunexPrinter Friendly Version
09/15/00Array BioPharma Inc. Announces Filing of Registration StatementPrinter Friendly Version
09/12/00Array BioPharma Inc. and Merck & Co. Inc. Expand Their Existing Compound Development and Supply AgreementPrinter Friendly Version
08/03/00Icos and Array BioPharma Expand Drug Discovery CollaborationPrinter Friendly Version
07/12/00Array BioPharma Doubles Laboratory SpacePrinter Friendly Version
05/10/00Array BioPharma and Tularik Announce Library Synthesis AgreementPrinter Friendly Version
03/28/00Array BioPharma Forms Chemistry-Based Research Agreement with Lilly for Drug DiscoveryPrinter Friendly Version
03/13/00Array BioPharma Announces Library Agreement with Asahi Chemical Industry Co., LtdPrinter Friendly Version
12/07/99Array BioPharma, Inc. Raises $8 Million in Second Round FinancingPrinter Friendly Version
11/30/99Array BioPharma Names Robert E. Conway as Chief Executive OfficerPrinter Friendly Version
10/12/99Neurocrine and Array BioPharma Announce Drug Discovery CollaborationPrinter Friendly Version
08/04/99Array BioPharma Announces Library Agreement with TularikPrinter Friendly Version
05/28/99Chiroscience and Array BioPharma Enter Compound Library AgreementPrinter Friendly Version
02/09/99Icos and Array BioPharma announce Drug Discovery CollaborationPrinter Friendly Version